 |
|
|
| |
Similar Virologic Outcomes and Frequency of Isolated Viremic Events (Blips, Low-Level Viremia and Suspected Virologic Failure) Between Oral and Long-acting Antiretroviral Therapy: A Pooled Analysis of Phase 3/3b Cabotegravir + Rilpivirine Long-Acting Studies
|
| |
| |
HIV Drug Therapy Glasgow; November 10-13, 2024; Glasgow, Scotland
John Thornhill1, Louise Garside2, Chinyere Okoli1, Patricia de los Rios3, Kimberley Brown4, Lori A. Gordon4, Christine L. Latham4, William Spreen4
1ViiV Healthcare, London, United Kingdom; 2PHASTAR, Macclesfield, United Kingdom; 3ViiV Healthcare, Laval, QC, Canada; 4ViiV Healthcare, Durham, NC, United States
|
| |
|
|
|
|
|
